The putative β4-adrenergic receptor is a novel state of the β1-adrenergic receptor

American Journal of Physiology - Endocrinology and Metabolism

Volumn 280, Issue 2 43-2, 2001, Pages

  Granneman, James G ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Catecholamines; Lipolysis receptor sites and receptor proteins; LY 362884; Phenethanolamines; Propranolol; Thermogenesis

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; BETA ADRENERGIC RECEPTOR; BUPRANOLOL; LY 362884; PROPANOLAMINE DERIVATIVE; PROPRANOLOL; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; ISOPROTEIN;

LIPOLYSIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW; THERMOGENESIS; TISSUE SPECIFICITY; ANIMAL; CLASSIFICATION; HUMAN; PHARMACEUTICS; PHYSIOLOGY;

ANIMALS; HUMANS; PROTEIN ISOFORMS; RECEPTORS, ADRENERGIC, BETA; TECHNOLOGY, PHARMACEUTICAL;

EID: 0035020878     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2001.280.2.e199     Document Type: Review

References (33)

1. Arch JR, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wilson C, and Wilson S. Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 309: 163-165, 1984.
2. Arch JR and Wilson S. Prospects for β3-adrenoceptor agonists in the treatment of obesity and diabetes. Int J Obes Relat Metab Disord 20: 191-199, 1996.
3. Bousquet-Mélou A, Galitzky J, Lafontan M, and Berlan M. Control of lipolysis in intra-abdominal fat cells of nonhuman primates: comparison with humans. J Lipid Res 36: 451-461, 1995.
4. Emorine LJ, Marullo S, Briend-Sutren MM, Patey G, Tate K, Delavier-Klutchko C, and Strosberg AD. Molecular characterization of the human beta 3-adrenergic receptor. Science 246: 1118-1121, 1989.
5. 4-adrenoceptor. Br J Pharmacol 122: 1244-1250, 1997.
6. 3-adrenergic receptor. Mol Pharmacol 40: 885-899, 1991.
7. 3-adrenergic receptor gene. Mol Pharmacol 44: 264-270, 1993.
8. Granneman JG and Whitty C. CGP 12177A modulates brown fat adenylate cyclase activity by interacting with two distinct receptor sites. J Pharmacol Exp Ther 256: 421-425, 1991.
9. Harms HH, Zaagsma J, and de Vente J. Differentiation of beta-adrenoceptors in right atrium, diaphragm and adipose tissue of the rat, using stereoisomers of propranolol, alprenolol, nifenalol and practolol. Life Sci 21: 123-128, 1977.
10. Ito M, Grujic D, Abel ED, Vidal-Puig A, Susulic VS, Lawitts J, Harper ME, Himms-Hagen J, Strosberg AD, and Lowell BB. Mice expressing human but not murine beta3-adrenergic receptors under the control of human gene regulatory elements. Diabetes 47: 1464-1471, 1998.
11. Kaumann AJ. (-)-CGP 12177-induced increase of human atrial contraction through a putative third β-adrenoceptor. Br J Pharmacol 117: 93-98, 1996.
12. 3-adrenoceptor in the rat. Br J Pharmacol 118: 2085-2098, 1996.
13. Kaumann AJ and Molenaar P. Modulation of human cardiac function through 4 β-adrenoceptor populations. Naunyn Schmiedebergs Arch Pharmacol 355: 667-681, 1997.
14. 3-adrenoceptor knockout mice. Mol Pharmacol 53: 670-675, 1998.
15. Kenakin TP, Bond RA, and Bonner TI. Definition of pharmacological receptors. Pharmacol Rev 44: 351-362, 1992.
16. 4-adrenoceptor mediated responses occur in parallel in a rat model of cardiac failure. Br J Pharmacol 128: 1399-1406, 1999.
17. 3-adrenergic-independent effects of CGP 12177 in brown adipose tissue. Mol Pharmacol 57: 252-258, 2000.
18. Konkar AA, Zhu Z, and Granneman JG. Aryloxypropanolamine and catecholamine ligand interactions with the β1-adrenergic receptor: evidence for interaction with distinct conformations of β1-adrenergic receptors. J Pharmacol Exp Ther 294: 923-932, 2000.
19. 3-adrenoceptor in man. Br J Pharmacol 110: 929-936, 1993.
20. 3-adrenoceptors in the pithed rat. Br J Pharmacol 122: 1307-1314, 1997.
21. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, and Foord SM. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393: 333-339, 1998.
22. 3H]CGP-12177, generally classified as an antagonist, is a thermogenic agonist in brown adipose tissue. Biochem J 261: 401-405, 1989.
23. 4-adrenoceptor" in mammalian heart. Clin Exp Pharmacol Physiol 24: 647-656, 1997.
24. Muff R, Buhlmann N, Fischer JA, and Born W. An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3. Endocrinology 140: 2924-2927, 1999.
25. Overton MC and Blumer KJ. G-protein-coupled receptors function as oligomers in vivo. Curr Biol 10: 341-344, 2000.
26. 1-adrenergic receptors. J Recept Signal Transduct Res 16: 1-23, 1996.
27. 3-adrenoceptor knockout mice: evidence for a new β-adrenergic receptor in brown adipose tissue. Br J Pharmacol 124: 1684-1688, 1998.
28. 2-adrenergic receptor. Mol Pharmacol 45: 390-394, 1994.
29. s interactions: evidence for multiple receptor conformations. Mol Pharmacol 56: 348-358, 1999.
30. Staehelin M, Simons P, Jaeggi K, and Wigger N. CGP-12177. A hydrophilic β-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. J Biol Chem 258: 3496-3502, 1983.
31. Susulic VS, Frederich RC, Lawitts J, Tozzo E, Kahn BB, Harper ME, Himms-Hagen J, Flier JS, and Lowell BB. Targeted disruption of the β3-adrenergic receptor gene. J Biol Chem 270: 29483-29492, 1995.
32. 3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes. J Lipid Res 37: 87-97, 1996.
33. 3-adrenoceptor agonist, on lipolysis of human and rat adipocytes. Harm Metab Res 28: 394-396, 1996.